Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
Sonali Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 467-467
Open Access | Times Cited: 23

Showing 23 citing articles:

MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Junjiang Fu, Saber İmani, Mei-Yi Wu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4723-4723
Open Access | Times Cited: 45
The role of miRNAs as biomarkers in breast cancer
Temesgen Baylie, Mulugeta Kasaw, Mamaru Getinet, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
The evidence for repurposing anti-epileptic drugs to target cancer
Mir Aroosa, Jonaid Ahmad Malik, Sakeel Ahmed, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7667-7680
Open Access | Times Cited: 12
Dynamic RNA synthetic biology: new principles, practices and potential
Yueyi Li, Aníbal Arce, Tyler Lucci, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 817-829
Open Access | Times Cited: 11
Current state of cancer immunity cycle: new strategies and challenges of using precision hydrogels to treat breast cancer
Yan Zhu, Yanlin Su, Yaxin Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
In silico identification of multidrug resistance gene (MDR)-targeted transposon miRNAs in human cancer
Seda Mesci
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2025) Vol. 830, pp. 111903-111903
Closed Access
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential
Junjiang Fu, Saber İmani, Mei-Yi Wu, et al.
(2023)
Open Access | Times Cited: 10
Oral delivery of miR-146a-5p overexpression plasmid-loaded Pickering double emulsion modulates intestinal inflammation and the gut microbe
Jiahao Zhu, Yaotian Fan, Yang Song-feng, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129733-129733
Closed Access | Times Cited: 3
Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics
Ghazala Muteeb, Doaa S. R. Khafaga, Manar T El-Morsy, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37217-e37217
Open Access | Times Cited: 3
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5557-5557
Open Access | Times Cited: 7
MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications
Fatemeh Hosseinpour-Soleimani, Zahra Salmasi, Younes Ghasemi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28167-e28167
Open Access | Times Cited: 2
The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
Helen Huang, Sarah M. Badar, Mohammad Said, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
In vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis
R.L. Akshaya, I. Saranya, G. Margaret Salomi, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 1
Clinical and biological significance of microRNA-127 and microRNA-138 expression in women with breast cancer: response to treatment and survival impact
Ghada M. Nasr, Mohamed F. Elshal, Eman Abdel-Ghani Gobran, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
MicroRNA‐1307‐3p contributes to breast cancer progression through PRM2
José Roberto Estupiñan‐Jiménez, Valeria Villarreal‐García, Vianey González-Villasana, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 32, pp. 2298-2308
Open Access | Times Cited: 1
Non-coding RNAs mediated inflammation in breast cancers
Dan Wang, Guanghao Yin
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 215-220
Closed Access | Times Cited: 3
Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells
Jowaher Alanazi, Onur Bender, Rumeysa Dogan, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5253-5253
Open Access | Times Cited: 2
Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine
Jeba Ajgar Ansari, Jonaid Ahmad Malik, Sakeel Ahmed, et al.
Pharmacology (2023) Vol. 108, Iss. 6, pp. 504-520
Open Access | Times Cited: 2
Resistance to Endocrine Therapy in Breast Cancer
Demetra Demetriou, Richard Khanyile, Zukile Mbita, et al.
(2024), pp. 105-128
Closed Access
A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia
Tuulikki Suomela, Liang Zhang, Julio Vera, et al.
Methods in molecular biology (2024), pp. 403-426
Closed Access
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges
Mostafa Yazdan, Seyed Morteza Naghib, M. R. Mozafari
Current Drug Targets (2024) Vol. 25, Iss. 10, pp. 649-669
Closed Access
miRNA-Based Therapeutic Strategy and Its Application in Breast Cancer
Sema Mısır, Serap Özer Yaman, Osman Akidan, et al.
IntechOpen eBooks (2024)
Open Access
Design, Synthesis, In Silico Studies, and Anticancer Activity of Novel Nitrobenzene Thiazolyl Hydrazones against the EGFR
Sonali Shinde, Jaydeo T. Kilbile, Shankar Thapa, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 6, pp. 2483-2498
Closed Access
Page 1

Scroll to top